4th Quarter - Report
SAREPTA THERAPEUTICS, INC. for SAREPTA THERAPEUTICS, INC.
Client
Income
—
Expenses
$230,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Patient Access to Treatments Newborn Screening for Rare Diseases
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIP PAYNE | — |
Science/Technology SCI
Scientific Innovation in Healthcare Gene Therapies Rare Diseases Artificial Intelligence and Data Governance
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIP PAYNE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.